5443-06-1 Usage
Uses
Used in Pharmaceutical Applications:
2-(4-phenacylpiperazin-1-yl)-1-phenyl-ethanone is utilized as a therapeutic agent for the treatment of various neurological and psychiatric disorders. Its application is based on its ability to stimulate the central nervous system, which may provide relief for conditions such as depression and anxiety.
Used in Recreational Drug Context:
While not a primary intended use, 2-(4-phenacylpiperazin-1-yl)-1-phenyl-ethanone has been studied for its psychoactive effects. It is used as a recreational drug by some individuals due to its ability to produce stimulating and psychoactive effects. However, it is important to note that the recreational use of 2-(4-phenacylpiperazin-1-yl)-1-phenyl-ethanone may carry significant health risks and is not endorsed or recommended.
Used in Research and Development:
In the context of research and development, 2-(4-phenacylpiperazin-1-yl)-1-phenyl-ethanone serves as a valuable compound for studying the effects of central nervous system stimulants. It is used in scientific investigations to better understand the mechanisms of action and potential therapeutic applications in the treatment of neurological and psychiatric conditions.
It is crucial to emphasize that the use of 2-(4-phenacylpiperazin-1-yl)-1-phenyl-ethanone in any context should be approached with caution, given its potential for abuse and the need for further research to fully understand its effects and safety profile.
Check Digit Verification of cas no
The CAS Registry Mumber 5443-06-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,4 and 3 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 5443-06:
(6*5)+(5*4)+(4*4)+(3*3)+(2*0)+(1*6)=81
81 % 10 = 1
So 5443-06-1 is a valid CAS Registry Number.
5443-06-1Relevant academic research and scientific papers
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPASE
-
Paragraph 00254, (2019/04/09)
Compounds of general formula IA, IB and IC outlined below, including pharmaceutically acceptable salts, solvates and hydrates thereof. Such compounds and pharmaceutical compositions comprising them may be used in medical conditions involving Ran GTPase.
